Thomas X - Search Results

1

Minimally differentiated acute myeloid leukemia (FAB AML-M0): prognostic factors and treatment effects on survival--a retrospective study of 42 adult cases.

Gougounon A, Abahssain H, Rigollet L, Elhamri M, Tigaud I, Chelghoum Y, Plesa A, Dumontet C, Michallet M, Thomas X. Gougounon A, et al. Among authors: thomas x. Leuk Res. 2011 Aug;35(8):1027-31. doi: 10.1016/j.leukres.2011.02.015. Epub 2011 Mar 12. Leuk Res. 2011. PMID: 21397944

2

Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.

Archimbaud E, Thomas X, Campos L, Magaud JP, Doré JF, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Apr;6(4):265-71. Leukemia. 1992. PMID: 1375302

3

Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.

Archimbaud E, Thomas X, Campos L, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leuk Res. 1992 Jun-Jul;16(6-7):673-80. doi: 10.1016/0145-2126(92)90018-3. Leuk Res. 1992. PMID: 1378919

4

Maintenance with low-dose cytarabine for acute myeloid leukemia in complete remission.

Archimbaud E, Anglaret B, Thomas X, Jaubert J, Sebban C, Guyotat D, Fiere D. Archimbaud E, et al. Among authors: thomas x. Ann Hematol. 1992 Aug;65(2):71-4. doi: 10.1007/BF01698132. Ann Hematol. 1992. PMID: 1511060 Clinical Trial.

5

Continuous-infusion daunorubicin and carboplatin for high-risk acute myeloid leukemia in the elderly.

Archimbaud E, Anglaret B, Thomas X, Devaux Y, Ffrench M, Sebban C, Troncy J, Fiere D. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1992 Aug;6(8):776-9. Leukemia. 1992. PMID: 1640728

6

High risk myelodysplastic syndrome coexistent with chronic lymphocytic leukemia for more than 9 years: inhibition of the myeloid clone by the lymphoid clone?

Bastion Y, Thomas X, Felman P, Campos L, Charrin C, Coiffier B. Bastion Y, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):1006-9. Leukemia. 1991. PMID: 1961029

7

Susceptibility of adult acute lymphoblastic leukemia blasts to lysis by lymphokine-activated killer cells.

Archimbaud E, Thomas X, Campos L, Magaud JP, Fiere D, Doré JF. Archimbaud E, et al. Among authors: thomas x. Leukemia. 1991 Nov;5(11):967-71. Leukemia. 1991. PMID: 1961038

8

CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.

Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. Thomas X, et al. Leukemia. 1995 Feb;9(2):249-53. Leukemia. 1995. PMID: 7532767

9

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.

Archimbaud E, Thomas X, Leblond V, Michallet M, Fenaux P, Cordonnier C, Dreyfus F, Troussard X, Jaubert J, Travade P, et al. Archimbaud E, et al. Among authors: thomas x. J Clin Oncol. 1995 Jan;13(1):11-8. doi: 10.1200/JCO.1995.13.1.11. J Clin Oncol. 1995. PMID: 7799010

10

Sequential induction chemotherapy with vincristine, daunorubicin, cyclophosphamide, and prednisone in adult acute lymphoblastic leukemia.

Thomas X, Danaïla C, Bach QK, Dufour P, Christian B, Corront B, Bosly A, Bastion Y, Gratecos N, Leblay R, et al. Thomas X, et al. Ann Hematol. 1995 Feb;70(2):65-9. doi: 10.1007/BF01834381. Ann Hematol. 1995. PMID: 7880925 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

448 results

Search Page

Filters